Pure Global AI
NCT06229470Recruiting

Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain

A Prospective, Multicenter, Single-arm Study Evaluating the Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop Spinal Cord Stimulation (SCS) to Guide Treatment of Patients With Chronic Pain of the Trunk and/or Limbs.
Saluda Medical Pty LtdClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Chronic Pain
Drug/Device/Intervention
Evoke Spinal Cord Stimulation (SCS) System
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Saluda Medical Pty Ltd
Location
Camarillo,La Mesa,Louisville,Grand Island,Reno,Loveland, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2024
End date
Feb 28, 2027
Enrollment
250 participants
Primary outcome

Change in Evoked Compound Action Potentials (ECAPs) as measured by the Evoke SCS System

Summary

The purpose of this study is to evaluate the clinical utility of neurophysiological
 measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide
 treatment of chronic pain of the trunk and/or limbs.

ICD-10 classifications
Other chronic painChronic intractable painPain, not elsewhere classifiedPain, unspecifiedPain associated with micturition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06229470
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06229470 through Pure Global AI's free database. This phase not specified trial is sponsored by Saluda Medical Pty Ltd and is currently Recruiting. The study focuses on Chronic Pain. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.